Aigen Investment Management’s Integra LifeSciences IART Stock Holding History

Aigen Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,122	Closed	-$252K	–	890
2024 Q1	$252K	Buy	+7,122	New	+$285K	0.06%	486
2023 Q3	–	Sell	-36,952	Closed	-$1.52M	–	940
2023 Q2	$1.52M	Buy	+36,952	New	+$1.78M	0.22%	129
2022 Q4	–	Sell	-32,664	Closed	-$1.38M	–	648
2022 Q3	$1.38M	Buy	32,664 +23,009	+238%	+$1.18M	0.2%	145
2022 Q2	$522K	Buy	9,655 +3,918	+68%	+$235K	0.09%	298
2022 Q1	$369K	Buy	+5,737	New	+$378K	0.06%	329
2020 Q2	–	Sell	-3,142	Closed	-$140K	–	1028
2020 Q1	$140K	Buy	+3,142	New	+$165K	0.02%	804

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Aigen Investment Management's IART Position: Q2 2024 in Review

Aigen Investment Management sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 7,122 shares — an estimated $252K sold.

Aigen Investment Management first reported a position in IART in Q1 2020 and held it in 6 quarters. The position peaked at $1.52M in Q2 2023. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

Aigen Investment Management reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
Aigen Investment Management sold 7,122 Integra LifeSciences shares in Q2 2024, an estimated $252K.
Aigen Investment Management first reported a position in Integra LifeSciences in Q1 2020 and held it in 6 quarters.
Aigen Investment Management's Integra LifeSciences position peaked at $1.52M in Q2 2023.
238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.